Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
Clinical trial NCT01630590 · COMPLETED
Trial details
- NCT number
- NCT01630590
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-08
- Primary completion
- 2021-04-06
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.